Target: BRAF V600

Ivette Giancola tells CBS News that when she learned she had stage four pancreatic cancer, she wasn't sure she was going to make it.

"You hear the word 'metastasized' and it's very, very scary," she says.

However, CBS News says that Giancola was eligible to take part in a personalized medicine study using a therapeutic targeted to a genetic mutation found in her tumor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.